Grace S Rhim, MD in Ladera Ranch, CA - Allergy & Immunology

Grace S Rhim, MD is a Allergy & Immunology physician based in Ladera Ranch, California. Grace S Rhim is licensed to practice in California (license number A76139) and her current practice location is 5 Bell Pasture Rd, Ladera Ranch, California. She can be reached at her office (for appointments etc.) via phone at (949) 275-0672.

NPI number for Grace S Rhim is 1790829174 and her current mailing address is 5 Bell Pasture Rd, Ladera Ranch, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1790829174.

Contact Information

	Grace S Rhim, MD
	5 Bell Pasture Rd, Ladera Ranch, CA 92694-1412
	(949) 275-0672
	Not Available

Physician's Profile

Full Name	Grace S Rhim
Gender	Female
Speciality	Allergy & Immunology
Location	5 Bell Pasture Rd, Ladera Ranch, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1790829174
Provider Enumeration Date: 02/18/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Grace S Rhim such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1790829174	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	A76139 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Grace S Rhim is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Grace S Rhim, MD 5 Bell Pasture Rd, Ladera Ranch, CA 92694-1412 Ph: () -	Grace S Rhim, MD 5 Bell Pasture Rd, Ladera Ranch, CA 92694-1412 Ph: (949) 275-0672

News Archive

The endocannabinoid system controls key epileptogenic circuits in the hippocampus

The same brain machinery that responds to the active substance in marijuana provides a central "on-demand" protection against seizures, researchers have found. They said their discoveries suggest that the "endocannabinoid" system might constitute a prime target for drugs against seizures of epilepsy and other neurodegenerative diseases.

New research reveals link between sickle cell trait and increased risk of developing kidney failure

New research indicates that being born with one copy of the sickle gene puts an individual at elevated risk for developing kidney failure requiring dialysis.

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Alexion Pharmaceuticals, Inc. today announced that its two open-label Phase 2 studies investigating eculizumab (Soliris) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) have met the primary and key secondary endpoints with high clinical and statistical significance, in interim analyses.

Contraception, abortion issues crop up in state legislatures, political races

The debate over the birth control mandate is seeping into West Virginia's governor race as reproductive-rights supporters assess their place amid losses in state legislatures.

Grace S Rhim, MD - Allergy & Immunology in Ladera Ranch, CA